Thus, based on the relationship between CX3CL1 soluble levels with the angiogenic properties of MM patients, we next explored the contribution of the CX3CL1/CX3CR1 axis in MM-induced angiogenesis in pre-clinical models. This evidence concerns the gene CX3CL1 and Miyoshi myopathy.